COVID-19 Infection
102
11
26
42
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
13.7%
14 terminated out of 102 trials
75.0%
-11.5% vs benchmark
9%
9 trials in Phase 3/4
21%
9 of 42 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 42 completed trials
Clinical Trials (102)
NCI COVID-19 in Cancer Patients, NCCAPS Study
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
A Study of How Ibuzatrelvir is Taken up Into the Blood of Healthy Adults After Taking Different Tablets of Ibuzatrelvir
Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce
Well-Being and Health-Related Quality of Life in Cancer Patients and Survivors During the COVID-19 Pandemic
Evaluation of Immunologic Response Following COVID-19 Vaccination in Children, Adolescents, and Young Adults With Cancer
Integrated Mindfulness-based Health Qigong Intervention for COVID-19 Survivors and Caregivers
Covid-19 in Pregnancy: a French Population-based Cohort of Women and Newborns
Breathing Techniques and Meditation for Health Care Workers During COVID-19 Pandemic
The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors
A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia
Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia
Patient Perceptions of the Relational Empathy of Healthcare Practitioners From the Department of Emergency Medicine During the COVID-19 Pandemic
A Study on the Effects in Healthy People of a New Drug Called PDI204 for Treating COVID-19
Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery
Clinical Characteristics and Prognostic Factors of Patients With COVID-19 (Coronavirus Disease 2019)
Well-being in Cancer Patients With Neuropathy During COVID-19 Who Participated in Prior Clinical Trials
Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic
Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors
The Impact of COVID-19 on Pulmonary Procedures